Intake questionnaire
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Applying to Dana Farber Cancer Center · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 3 answered
Intake questionnaire
Applying to Dana Farber Cancer Center · Boston, Massachusetts
Answer a few short questions to share with the research team.
0 of 3 answered